Gastro Medical News about rectal cancer

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer
Histopathology, 09/04/09

Wang Q et al. – The CD133 antigen has been identified as a putative stem cell marker in colorectal cancer tissues. According to the cancer stem cell hypothesis, CD133+ cells determine long–term tumour growth and are therefore suspected of influencing clinical outcome. CD133 stem cell antigen expression correlates with patient survival in rectal cancer, lending support to the current cancer stem cell hypothesis.

<< Previous
Intraductal tubular adenoma (pyloric gland-type) of the pancreas:...

Next >>
Dependence of platelet function on underlying liver disease in...

Obesity linked to specific cancers
Internet Source, 11/05/09 Relevance Score: 69%

Plasma enterolactone and risk of colon and rectal cancer in a case–cohort study of Danish men and women
Cancer Causes and Control, 10/28/09 Relevance Score: 69%

Childhood Cancer Survivors Experience Suicidal Thoughts Decades After Diagnosis
ScienceDaily, 10/27/09 Relevance Score: 69%

American Cancer Society Stands by Cancer Screening Guidelines
MedLinePlus, 10/23/09 Relevance Score: 69%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09 Relevance Score: 69%